Tag Archives: Lilly

Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance  investor.lilly.com Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar  CNBC Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine  statnews.com Eli Lilly Smashes Views On Back Of Mounjaro, Zepbound  Investor’s Business Daily Obesity, diabetes treatments fuel Eli Lilly growth and spark …

Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings  The Wall Street Journal Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar  CNBC Lilly Ups Guidance on Weight Loss, Obesity Drugs’ Strength  Bloomberg.com Eli Lilly’s weight loss and diabetes drug tops Keytruda as world’s best-selling medicine  statnews.com Eli Lilly Stock Rises on Earnings and Boost to Guidance  Barron’s Source link

Eli Lilly Stock Rises on Earnings and Boost to Guidance  Barron’s Eli Lilly blows past estimates, hikes guidance as Zepbound and Mounjaro sales soar  CNBC Eli Lilly raises full-year forecast, as weight-loss drugs demand drives third-quarter beat  Yahoo Finance Lilly Raises Guidance on Strength of Weight Loss, Obesity Drugs  Bloomberg Eli Lilly stock pops on raised full-year outlook (LLY:NYSE)  Seeking Alpha Source link

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday reported third-quarter earnings and revenue that topped estimates and hiked its full-year outlook, as the company continued to see strong demand for its blockbuster weight loss drug Zepbound and diabetes treatment …

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly and Walmart on Wednesday said they have teamed up to expand access to the drugmaker’s weight loss drug Zepbound, allowing U.S. patients to get vials of the blockbuster injection at …

Eli Lilly Partners With Nvidia to Build AI Supercomputer for Drug Discovery  The Wall Street Journal Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development  CNBC Lilly Deploys World’s Largest, Most Powerful AI Factory for Drug Discovery Using NVIDIA Blackwell-Based DGX SuperPOD  NVIDIA Blog Lilly partners with Nvidia on AI supercomputer to speed up drug development  Reuters Eli Lilly, …

Eli Lilly and Nvidia are partnering to build what they call the pharmaceutical industry’s “most powerful” supercomputer and so-called AI factory to help accelerate drug discovery and development across the sector, the companies announced Tuesday.  It’s the latest stride by Nvidia and the pharmaceutical industry to harness AI to help shorten the time it takes to bring cures to patients, …

Eli Lilly, Novo Nordisk Stocks Drop. Trump Targets Ozempic, ‘Fat Loss’ Drug Prices.  Barron’s Novo Nordisk Shares Fall as Trump Moves to Cut Price of Weight-Loss Drugs  The Wall Street Journal Trump says Ozempic prices will be ‘much lower’ for Americans  Fox Business Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s  CNBC Novo, Lilly Fall as …

Novo Nordisk, Eli Lilly shares drop as Trump vows weight-loss drug price cuts  Reuters Trump says Ozempic will get cheaper. Novo Nordisk, Eli Lilly stock slump  qz.com Trump says price of Ozempic will be lowered  Reuters Novo Nordisk shares slide as Donald Trump vows to cut Ozempic price  Financial Times Trump: Cost of Ozempic Could Be $150. Dr. Oz: Not Yet.  The Wall Street Journal …

WASHINGTON — Peter Marks, the former top vaccine regulator at the Food and Drug Administration, has joined Eli Lilly to oversee molecule discovery and infectious diseases — a move that quickly drew criticism for the revolving door between the agency and industry. Marks confirmed his new role at Lilly Research Laboratories to STAT. His first day was Monday.  “I am excited about …